从2026年开始 医疗补助覆盖减重药物 Trump administration to pilot Medicare, Medicaid coverage for weight-loss drugs starting 2026.

特朗普政府计划从2026年开始实施一个为期五年的试点方案,以覆盖Ozempic和Zepbound等在医疗保健和医疗补助项目下的减重药物。 The Trump administration plans a five-year pilot program starting in 2026 to cover weight-loss drugs like Ozempic and Zepbound under Medicare and Medicaid. 这一政策转变的目的是评估这些药品的功效和成本节约,这些药品的重量可减少15-20%,但每年费用为5 000至7 000美元。 This shift in policy aims to evaluate the effectiveness and cost savings of these drugs, which can reduce weight by 15-20% but cost $5,000 to $7,000 annually. 医疗补助试点始于2026年4月,其次是2027年1月的医疗补助试点。 The Medicaid pilot begins in April 2026, followed by the Medicare pilot in January 2027.